Differences in the pathological patterns of non-specific pleuritis (NSP).

G. Karpathiou (Saint-Etienne, France), S. Hathroubi (Saint-Etienne, France), A. Patoir (Saint-Etienne, France), O. Tiffet (Saint-Etienne, France), F. Casteillo (Saint-Etienne, France), C. Brun (Saint-Etienne, France), F. Forest (Saint-Etienne, France), N. Rahman (Oxford, United Kingdom), M. Peoc'H (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France)

Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Session: Mesothelioma and pleural malignancy: investigations and management
Session type: Thematic Poster
Number: 2871
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Karpathiou (Saint-Etienne, France), S. Hathroubi (Saint-Etienne, France), A. Patoir (Saint-Etienne, France), O. Tiffet (Saint-Etienne, France), F. Casteillo (Saint-Etienne, France), C. Brun (Saint-Etienne, France), F. Forest (Saint-Etienne, France), N. Rahman (Oxford, United Kingdom), M. Peoc'H (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France). Differences in the pathological patterns of non-specific pleuritis (NSP).. 2871

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences and characteristics of COVID-19 and atypical pneumonia
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg.
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Clinical presentation on nonspecific (NSIP) compared to usual (UIP) interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001

Differences in inflammation biomarkers among COVID-19 and Non-COVID-19 pneumonia.
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011


Differences in pulmonary function tests (PFTs) in patients with usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001

Clinical significance of histological UIP pattern in interstitial pneumonia with autoimmune features (IPAF)
Source: International Congress 2017 – Novel and old entities
Year: 2017


CD8 BAL lymphocytosis differentiates usual interstitial pneumonia (UIP) from sarcoidosis (SA); correlation with clinical parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001

Different expression profiles of gelsolin in various types of idiopathic interstitial pneumonias (IIPs). A tissue microarray study
Source: Eur Respir J 2007; 30: Suppl. 51, 573s
Year: 2007

Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB)
Source: Eur Respir J 2006; 28: Suppl. 50, 308s
Year: 2006

Differences between age related clinical presentation of pulmonary tuberculosis (TB)
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011


Peripheral blood changes in usual interstitial pneumonia (UIP) and non specific interstitial pneumonia (NSIP), possible biomarkers of oxidative stress
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Comparison of fibroblastic foci scoring systems in usual interstitial pneumonia (UIP)
Source: Eur Respir J 2003; 22: Suppl. 45, 376s
Year: 2003

Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Corticosteroid (CS) therapy does not influence immune reactivity in patients with non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

Non-specific interstitial pneumonia (NSIP) - a study of 12 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

CT features of fibrosing alveolitis in rheumatoid arthritis (FARA): a comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP)
Source: Eur Respir J 2003; 22: Suppl. 45, 197s
Year: 2003

Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010